Furthermore, we investigated the clinical significance of STX6 expression in patients with HCC using Kaplan-Meier analysis and found that patients with HCC with high STX6 expression had a poor prognosis (overall survival [OS]; p = 0.0054), the results of the UALCAN database are consistent with our analysis of the TCGA database (Fig. S1D). The gene discussed is STX6; the disease is hepatocellular carcinoma.